Fulgent Genetics, Inc.
$493.71M- Market cap
- $543.43M
- Debt
- +$476.00K
- Cash
- −$50.19M
Capital structure 100% equity / 0% debt · EV / Revenue 1.53x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: FLGT stock price at discount vs TFC $19.75 current versus $30.06 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TFC's multiple
Implied fair value · at FLGT's multiple
Snapshot Sep 8, 9:49 AM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: FLGT FY 2025 (ended Dec 31, 2025) · TFC FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 100% equity / 0% debt · EV / Revenue 1.53x
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 47% equity / 53% debt
TFC carries the larger enterprise value at $132.72B against $493.71M; FLGT trades on the lower EV / Revenue multiple (1.53x vs 5.41x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
FULGENT GENETICS, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
TRUIST FINANCIAL CORPORATION · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.00x
1.07x
Net debt / EBITDA
Leverage against operating earnings
1.15x
—
Cash and equivalents
Liquid reserves on the balance sheet
$50.19M
—
Total debt
Interest-bearing obligations outstanding
$476.00K
$69.80B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NEOGENOMICS INC
FLGT vs NEO
Natera, Inc.
FLGT vs NTRA
Guardant Health, Inc.
FLGT vs GH
EXACT SCIENCES CORP
FLGT vs EXAS
OPKO HEALTH, INC.
FLGT vs OPK
PNC FINANCIAL SERVICES GROUP, INC.
FLGT vs PNC
US BANCORP \DE\
FLGT vs USB
FIFTH THIRD BANCORP
FLGT vs FITB
KEYCORP /NEW/
FLGT vs KEY
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.